528 Activated T cells engage IL-1 and TNFa-driven tumor inflammation to support immune checkpoint inhibitor resistance in inflammatory solid malignancies

• Eun Ji Kim,
• Barzin Y Nabet,
• Nam Woo Cho,
• Sophia M Guldberg,
• Kamir J Hiam-Galvez,
• Jacqueline L Yee,
• Rachel DeBarge,
• Katherine Wai,
• Lauren S Levine,
• Naa Asheley Ashitey,
• Matthew H Spitzer

Affiliations

Eun Ji Kim

1 Chemical Pathology, Guy`s and St Thomas` NHS Foundation Trust, London, UK

Barzin Y Nabet

Genentech, Inc., South San Francisco, CA, USA

Nam Woo Cho

1University of California San Francisco, San Francisco, CA, USA

Sophia M Guldberg

1University of California San Francisco, San Francisco, CA, USA

Kamir J Hiam-Galvez

1University of California San Francisco, San Francisco, CA, USA

Jacqueline L Yee

1University of California San Francisco, San Francisco, CA, USA

Rachel DeBarge

1University of California San Francisco, San Francisco, CA, USA

Katherine Wai

1University of California San Francisco, San Francisco, CA, USA

Lauren S Levine

1University of California San Francisco, San Francisco, CA, USA

Naa Asheley Ashitey

2Genentech Inc, South San Francisco, CA, USA

Matthew H Spitzer

2Genentech Inc, South San Francisco, CA, USA